Lyell Immunopharma, Inc. (LYEL)
NASDAQ · Healthcare
Lyell Immunopharma, Inc. Total Liabilities 2019–2025
Lyell Immunopharma, Inc. annual total liabilities history from 2020 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Lyell Immunopharma, Inc. total liabilities as of December 31, 2025: 91.8M, a 14.98% decrease year-over-year.
- Lyell Immunopharma, Inc. total liabilities for 2025 were 91.8M, a 14.98% decrease from 2024.
- Lyell Immunopharma, Inc. total liabilities for 2024 were 108.0M, a 13.63% increase from 2023.
- Lyell Immunopharma, Inc. total liabilities for 2023 were 95.1M, a 8.85% decrease from 2022.
- Lyell Immunopharma, Inc. total liabilities for 2022 were 104.3M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Lyell Immunopharma, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $92 |
| 2024 | $108 |
| 2023 | $95 |
| 2022 | $104 |
| 2021 | $198 |
| 2020 | $190 |
Lyell Immunopharma, Inc. Total Liabilities — FAQ
Lyell Immunopharma, Inc. (LYEL) total liabilities over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see LYEL's total liabilities history?
The chart and table above show Lyell Immunopharma, Inc.'s total liabilities by year and by quarter, including the growth rate.